Tech Center 1600 • Art Units: 1622 1624
This examiner grants 83% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18277522 | COMPOSITIONS AND METHODS FOR TREATING TAUOPATHIES | Non-Final OA | The Regents of the University of California |
| 17921051 | Aminopiperidine Amides, Derivatives, Compositions, and Uses Related to CXCR4 Modulation | Final Rejection | Emory University |
| 19225710 | INHIBITORS OF CHYMASE FOR USE IN THE SELECTIVE RESOLUTION OF THROMBI IN THROMBOTIC OR THROMBOEMBOLIC DISORDERS | Non-Final OA | Bayer Aktiengesellschaft |
| 18559805 | COMPOSITION COMPRISING AHAS AND/OR BHAS WHICH IS STABILIZED BY A COMBINATION OF MONOALKYL OR DIALKYL ISOSORBIDE, POLYETHYLENE GLYCOL-POLYPROPYLENE GLYCOL ETHER AND TWO HYDROGENATED OR NON-HYDROGENATED POLYOXYETHYLENATED PLANT OILS | Non-Final OA | L'OREAL |
| 18842728 | PCNA INHIBITORS AND USES THEREOF | Non-Final OA | CITY OF HOPE |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy